PAR
Click for more information
0.00% 26.5¢ paradigm biopharmaceuticals limited..

Ann: Investor Webinar, page-33

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. mattw77
    109 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    17/07/22
    20:21
    Post #: 62578075
    I read the 'partnering enquiry' as a way of other start up bio researchers/companies to engage PAR with an opportunity to partner, early stage opportunities, not for Big Pharma to register thier interest. I remember reading somewhere that PAR is always on the look out for other new opportunities...Just my thoughts
    PAR Price at posting: $1.03 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
right-arrow Created with Sketch.
NEWS MOU executed with leading maritime partner to advance plans for a multi-user transhipping facility in West Pilbara
right-arrow Created with Sketch.
LGP Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
right-arrow Created with Sketch.
NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
NEWS Form 20-F filed to explore U.S. market opportunities through proposed Nasdaq ADS listing, aligning with strategic global growth goals
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $92.81M
Open High Low Value Volume
27.0¢ 29.0¢ 25.5¢ $430.3K 1.585M

Buyers (Bids)

No. Vol. Price($)
1 5500 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 36162 3
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.